CIK 0001174940 · Non-accelerated filer<br>Smaller reporting company
ORAGENICS INC
Sign in to watch- Ticker
- OGEN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 593410522
- Phone
- 8132867900
- Business address
- 9015 TOWN CENTER PARKWAY, SUITE 143, LAKEWOOD RANCH, FL, 34202
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-30 | KOSKI ROBERT C Director | Sale | −42,357 | $0.11 | $4K | 1,102,295 |
| 2022-12-29 | KOSKI ROBERT C Director | Sale | −36,648 | $0.11 | $4K | 176,191 |
| 2022-12-15 | KOSKI ROBERT C Director | Sale | −140,497 | $0.18 | $25K | 1,144,652 |
| 2022-12-14 | KOSKI ROBERT C Director | Sale | −25,000 | $0.18 | $4K | 1,285,149 |
| 2022-12-14 | KOSKI ROBERT C Director | Sale | −4,503 | $0.18 | $788 | 1,310,149 |
| 2022-12-09 | KOSKI ROBERT C Director | Sale | −48,795 | $0.20 | $10K | 1,314,652 |
| 2022-12-08 | KOSKI ROBERT C Director | Sale | −13,036 | $0.20 | $3K | 1,363,447 |
| 2022-11-30 | KOSKI ROBERT C Director | Sale | −200,000 | $0.19 | $38K | 1,376,483 |
| 2022-11-29 | KOSKI ROBERT C Director | Sale | −200,000 | $0.19 | $38K | 1,576,483 |
| 2022-07-29 | KOSKI ROBERT C Director | Grant or award · Non-Employee Director Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-07-29 | POPE CHARLES L Director | Grant or award · Non-Employee Director Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-07-29 | Sullivan Michael O'Keefe Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-07-29 | Telling Fred Director | Grant or award · Non-Employee Director Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-07-29 | DUNTON ALAN W Director | Grant or award · Non-Employee Director Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-06-23 | Telling Fred Director | Grant or award · Non-Employee Director Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-06-23 | Murphy Kimberly M CEO and President | Grant or award · Employee Option (Right to Buy) | +800,000 | 800,000 | ||
| 2022-06-23 | Sullivan Michael O'Keefe Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-06-23 | Telling Fred Director | Grant or award · Non-Employee Director Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-06-17 | Telling Fred Director | Purchase | +10,084 | $0.29 | $3K | 1,010,000 |
| 2022-05-24 | Telling Fred Director | Purchase | +78,673 | $0.29 | $23K | 999,916 |
Page 3 of 7 · 130 trades